Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration

Neurology

Volumn 82, Issue 18, 2014, Pages 1605-1612

  Jack, Clifford R ^a   Wiste, Heather J ^a   Knopman, David S ^a   Vemuri, Prashanthi ^a   Mielke, Michelle M ^a   Weigand, Stephen D ^a   Senjem, Matthew L ^a   Gunter, Jeffrey L ^a   Lowe, Val ^a   Gregg, Brian E ^a   Pankratz, Vernon S ^a   Petersen, Ronald C ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; BIOLOGICAL MARKER; PITTSBURGH COMPOUND B;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; DISEASE COURSE; FEMALE; HETEROZYGOTE; HIPPOCAMPAL NEURODEGENERATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH ORGANIZATION; NERVE DEGENERATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATROPHY; COGNITION DISORDERS; FEMALE; HIPPOCAMPUS; HUMANS; LINEAR MODELS; MALE; NERVE DEGENERATION; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY SCANNERS, X-RAY COMPUTED;

EID: 84902166246     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000386     Document Type: Article

References (40)

1. Sperling RA, Aisen PS, Beckett L.A., et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:280-292.
2. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging and Alzheimer's Association Workgroup. Alzheimers Dement 2011; 7:270-279.
3. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging and the Alzheimer's Association Workgroup. Alzheimers Dement 2011; 7:263-269.
4. Jack CR J.r., Knopman DS, Jagust W.J., et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol 2010; 9:119-128.
5. Jack CR J.r., Knopman DS, Weigand S.D., et al. An operational approach to NIA-AA criteria for preclinical Alzheimer's disease. Ann Neurol 2012; 71:765-775.
6. Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging 1997; 18:351-357. (Pubitemid 27435070)
7. Price JL, Morris JC Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann Neurol 1999; 45:358-368. (Pubitemid 29120041)
8. Haroutunian V, Purohit DP, Perl D.P., et al. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol 1999; 56:713-718. (Pubitemid 29266472)
9. Villain N, Fouquet M, Baron J.C., et al. Sequential relationships between grey matter and white matter atrophy and brain metabolic abnormalities in early Alzheimer's disease. Brain 2010; 133:3301-3314.
10. Jack CR J.r., Knopman DS, Jagust W.J., et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013; 12:207-216.
11. Vemuri P, Whitwell JL, Kantarci K, et al. Antemortem MRI based STructural Abnormality iNDex (STAND)-scores correlate with postmortem Braak neurofibrillary tangle stage. Neuroimage 2008; 42:559-567.
12. Klunk WE, Engler H, Nordberg A., et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B. Ann Neurol 2004; 55:306-319. (Pubitemid 38269583)
13. Senjem ML, Gunter JL, Shiung M.M., Petersen RC, Jack CR Jr. Comparison of different methodological implementations of voxel-based morphometry in neurodegenerative disease. Neuroimage 2005; 26:600-608. (Pubitemid 40723618)
14. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008; 131:665-680. (Pubitemid 351294719)
15. Jack CRJr, Wiste HJ, Lesnick TG, et al.. Brain beta-amyloid load approaches a plateau. Neurology 2013; 80:890-896.
16. Gunter JL, Senjem ML, Vemuri P, Jack CR Comparison of mask-based differences, boundary shift integral and symmetric normalization Jacobian integration. Presented at MICCAI, October 5, 2012, Nice, France.
17. Avants BB, Epstein CL, Grossman M, Gee JC Symmetric diffeomorphic image registration with cross-correlation: evaluating automated labeling of elderly and neurodegenerative brain. Med Image Anal 2008; 12:26-41. (Pubitemid 351189163)
18. Ikonomovic MD, Klunk WE, Abrahamson E.E., et al. Postmortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease. Brain 2008; 131:1630-1645. (Pubitemid 351806448)
19. 11C] PiB positron emission tomography and neuropathologic assessment in older adults. Arch Neurol 2011; 68:232-240.
20. Bobinski M, de Leon MJ, Wegiel J, et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience 2000; 95:721-725.
21. Whitwell JL, Josephs KA, Murray M.E., et al. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology 2008; 71:743-749.
22. Josephs KA, Whitwell JL, Ahmed Z, et al. Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol 2008; 63:204-212. (Pubitemid 351355299)
23. Jack CR J.r., Dickson DW, Parisi J.E., et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002; 58:750-757. (Pubitemid 34211554)
24. Sonnen JA, Santa Cruz K, Hemmy LS, et al. Ecology of the aging human brain. Arch Neurol 2011; 68:1049-1056.
25. Jagust W. Vulnerable neural systems and the borderland of brain aging and neurodegeneration. Neuron 2013; 77: 219-234.
26. Chien DT, Bahri S, Szardenings A.K., et al. Early clinical PET imaging results with the novel PHF-tau Radioligand [F-18]-T807. J Alzheimers Dis 2013; 34:457-468.
27. Villain N, Chetelat G, Grassiot B., et al. Regional dynamics of amyloid-beta deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. Brain 2012; 135:2126-2139.
28. Villemagne VL, Burnham S, Bourgeat P., et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol 2013; 12:357-367.
29. Jack CR J.r., Vemuri P, Wiste H.J., et al. Shapes of the Trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol 2012; 69:856-867.
30. Schott JM, Bartlett JW, Fox N.C., Barnes J. Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Abeta1-42. Ann Neurol 2010; 68: 825-834.
31. Chetelat G, Landeau B, Eustache F., et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI: a longitudinal MRI study. Neuroimage 2005; 27:934-946. (Pubitemid 41317262)
32. Desikan RS, McEvoy LK, Thompson W.K., et al. Amyloid-beta associated volume loss occurs only in the presence of phospho-tau. Ann Neurol 2011; 70:657-661.
33. Knopman DS, Jack CR Jr, Wiste HJ, et al. Selective worsening of brain injury biomarker abnormalities in cogni-tively normal elderly persons with beta-amyloidosis. JAMA Neurol 2013; 70:1030-1038.
34. Hardy J, Selkoe DJ The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353-356. (Pubitemid 34790756)
35. Small SA, Duff K. Linking Abeta and tau in late-ons et al.zheimer's disease: a dual pathway hypothesis. Neuron 2008; 60:534-542.
36. Chetelat G. Alzheimer disease: Abeta-independent processes-rethinking preclinical AD. Nat Rev Neurol 2013; 9:123-124.
37. Knopman DS, Jack CR Jr, Wiste HJ, et al. Brain injury biomarkers are not dependent on beta-amyloid in normal elderly. Ann Neurol 2013; 73:472-480.
38. Braak H, Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 2011; 121:171-181.
39. Liu L, Drouet V, Wu J.W., et al. Trans-synaptic spread of tau pathology in vivo. PLoS One 2012; 7:e31302.
40. Jack CR J.r., Lowe VJ, Weigand S.D., et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease. Brain 2009; 132:1355-1365.